Marek Ciszewski | Investor Relations |
Denny Lanfear | Chief Executive Officer |
Rosh Dias | Chief Medical Officer |
Paul Reider | Chief Commercial Officer |
McDavid Stilwell | Chief Financial Officer |
Ken Cacciatore | Cowen and Company |
Douglas Tsao | H.C. Wainwright & Company |
Jason Gerberry | Bank of America |
Ash Verma | UBS |
Ladies and gentlemen, thank you for standing by, and welcome to the Q2 2022 Coherus BioSciences, Inc. Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Marek. Please go ahead.
Thank you, Mandeep.